Found 6 matching trials
A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
PHASE2The study was conducted to determine if cenicriviroc mesylate (CVC) would d...
Location
University of California, Los Angeles CARE Center CRS (Site # 601)
Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination
PHASE1This is a Phase 1, Single and Multiple-Dose, Open-Label Study in Healthy Su...
Location
SeaView Research, Inc.
Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients
PHASE2The aim of this study is to test Cenicriviroc (CVC) as a means to reduce th...
Location
Medical Department of Hepatology and Gastroenterology, Charité University Medicine, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM)
Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
PHASE2The purpose of this study is to evaluate the effects of cenicriviroc mesyla...
Location
Multiple Locations
Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin
PHASE1This is a Phase 1, Open-Label, 3-Period, Single-sequence, Drug-drug Interac...
Location
Multiple Locations
Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination
PHASE1A single center, open-label, fixed sequence study to evaluate the pharmacok...
Location
DaVita Clinical Research